Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies

BACKGROUND: Dual antiplatelet therapy (DAPT) in the form of aspirin plus a P(2)Y(12) inhibitor, when indicated, is one of the key treatments in coronary artery disease (CAD). Many recommendations on DAPT in patients with CAD based on current guidelines are largely inconsistent. In our current study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shaozhao, Zhou, Huimin, Zhuang, Xiaodong, Yang, Daya, Sun, Xiuting, Zhong, Xiangbin, Lin, Xiaoyu, Hu, Xun, Huang, Yiquan, Liao, Xinxue, Du, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906997/
https://www.ncbi.nlm.nih.gov/pubmed/31609463
http://dx.doi.org/10.1002/clc.23275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906997/
https://www.ncbi.nlm.nih.gov/pubmed/31609463
http://dx.doi.org/10.1002/clc.23275

Ejemplares similares